Sublingual Misoprostol versus Manual Vacuum Aspiration in the Management of Incomplete Miscarriage at Katsina; a Multicentre Randomized Controlled Trial
Not Applicable
- Conditions
- Miscarriage
- Registration Number
- PACTR202310863957659
- Lead Sponsor
- Self
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 170
Inclusion Criteria
Consenting pregnant women who present with incomplete first trimester miscarriage who are haemodynamically stable
Exclusion Criteria
1.Women in shock
2.Patients with allergy to prostaglandins
3.Those with evidence of genital tract infection
4.Patients with background cardiovascular disease, sickle cell disease or bleeding disorder, liver or renal disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome measure will be proportion of women with completed uterine evacuation (completed miscarriage) after one week of treatment with MVA or single-dose sublingual misoprostol 400mcg
- Secondary Outcome Measures
Name Time Method 1.To compare the duration of vaginal bleeding after the treatment offered; this will be by asking specific questions on number of days spent having vaginal bleeding, whether she is currently having vaginal bleeding and the woman’s assessment of the severity of the vaginal bleeding on the follow up day <br>2.To compare the rate of genital tract infection after the treatment. This will involve asking questions on foul smelling vaginal discharge, worsening lower abdominal pain and fever<br>3.To compare patients’ satisfaction with the treatment method using 5-point Likert scale<br>